查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1362910

分叉病變市場規模、佔有率、趨勢分析報告：按用途、區域、細分趨勢，2023-2030

Bifurcation Lesions Market Size, Share & Trends Analysis Report By Application (Coronary Vascular, Peripheral Vascular), By Region (North America, Asia Pacific, Europe), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

分叉病變市場成長與趨勢：

根據Grand View Research, Inc.最新報告，到2030年，全球分叉病變市場規模預計將達到34.8億美元，預測期內年複合成長率為5.9%。

政府對技術開發和報銷的支持措施可能會在預測期內推動市場。

不斷成長的老年人口和不健康的生活方式是心血管疾病發病率不斷增加的原因。此外，創新設備的核准和商業化的增加以及未來年度用於治療分叉病變的新設備的預期進入也可能推動市場。

此外，負擔能力的提高、微創手術需求的增加以及醫療旅遊的增加等要素也推動了全球對分叉病變手術的需求。根據各種研究，針對冠狀動脈分叉病變的手術約佔所有經皮冠狀動脈介入治療的20%。

分叉病變市場報告亮點

  • 分叉病變設備商業化的增加以及產業參與者對研發的投資是推動市場上升的要素，預計2023年至2030年的年複合成長率約為5.9%。
  • 由於心臟記憶體在複雜的血管網路、設備可用性的增加以及人們對分叉病變手術干涉的認知不斷增強，冠狀血管部分在 2022 年將佔據最大的市場佔有率。
  • 由於產業參與者增加了開發週邊應用設備的投資，以及有助於準確檢測斑塊的診斷技術的進步，末稍血管領域可能在未來年度呈現良好的成長。
  • 按地區分類，2022年北美佔據分叉病變市場最大佔有率。由於藥物釋放型支架的需求不斷增加、分叉病變裝置的商業化以及主要市場參與者在當地的存在，預計它將保持其主導地位。
  • 由於醫療基礎設施、醫療旅遊業的改善以及該地區市場參與者的投資增加，亞太地區預計將在未來年度經歷最快的成長。
  • Tryton Medical, Inc.開發了球囊擴張式Tryton側支支架，可放置在側支動脈中用於治療分叉病變。該支架銷往美國、歐洲和中東/非洲。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 分叉病變市場變數、趨勢和範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 分岔病變市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 分叉病變：用途估計及趨勢分析

  • 分叉病變市場：要點
  • 分叉病變市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 末稍血管
  • 冠狀血管

第5章 分叉病變市場：區域估計與趨勢分析

  • 區域預測
  • 按地區分類的分叉病變市場：市場要點
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第6章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Boston Scientific Corporation
    • Abbott
    • Cardinal Health
    • Medtronic
    • CR Bard, Inc.
    • Johnson and Johnson Services, Inc.
    • Spectranetics
    • Terumo Medical Corporation
    • Tryton Medical Inc.
Product Code: GVR-1-68038-534-2

Bifurcation Lesions Market Growth & Trends:

The global bifurcation lesions market size is expected to reach USD 3.48 billion by 2030, registering a CAGR of 5.9% during the forecast period, according to a new report by Grand View Research, Inc.. Technological developments and supportive government initiatives for reimbursement are likely to drive the market during the forecast period.

The increasing geriatric population and unhealthy lifestyle are responsible for growth in the incidence of cardiovascular disorders. Furthermore, an increase in approval & commercialization of innovative devices and the expected entry of new devices for the treatment of bifurcation lesions in the coming years are likely to drive the market.

In addition, factors such as rising affordability, increase in demand for minimally invasive procedures, and growing medical tourism are also boosting demand for bifurcation lesions procedures across the globe. According to various studies, procedures for coronary bifurcation lesions comprise approximately 20% of total percutaneous coronary interventions.

Bifurcation Lesions Market Report Highlights:

  • Increase in the commercialization of devices for bifurcation lesions and investments by industry players for R&D are the factors expected to boost the market, resulting in an anticipated CAGR of around 5.9% from 2023 to 2030
  • The coronary vascular segment accounted for the maximum share of the market in 2022 due to the presence of complex vascular network in heart, increased availability of devices, and rise in awareness regarding surgical interventions for bifurcation lesions.
  • The peripheral vascular segment is likely to witness lucrative growth in the coming years due to an increase in investments by industry players for the development of devices for peripheral application and advancements in diagnostics facilitating accurate detection of plaque.
  • Geographically, North America held the largest share of the bifurcation lesions market in 2022. It is anticipated to maintain its dominance in the coming years due to increasing demand for drug-eluting stents, commercialization of devices for bifurcation lesions, and the local presence of major market players.
  • The Asia Pacific is expected to observe the fastest growth over the next decade owing to improvement in healthcare infrastructure, medical tourism, and a rise in investments by market players in the region.
  • Some of the key players in the market are Abbott; Boston Scientific Corporation; Cardinal Health; Medtronic; Johnson & Johnson Services, Inc.; C. R. Bard, Inc.; Spectranetics; and Terumo Medical Corporation. Tryton Medical, Inc. developed the Tryton Side Branch Stent with a balloon-expandable, single-wire stent delivery system that can be deployed in the side branch artery for treatment of bifurcation lesions. The device is available in the U.S. and Europe as well as Middle East & Africa.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Bifurcation Lesions Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Bifurcation Lesions Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Bifurcation Lesions: Application Estimates & Trend Analysis

  • 4.1. Bifurcation Lesions Market: Key Takeaways
  • 4.2. Bifurcation Lesions Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Peripheral Vascular
    • 4.3.1. Peripheral vascular market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Coronary Vascular
    • 4.4.1. Coronary vascular market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Bifurcation Lesions Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Bifurcation Lesions Market by Region: Key Marketplace Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Boston Scientific Corporation
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Abbott
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Cardinal Health
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Medtronic
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. C. R. Bard, Inc.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Johnson and Johnson Services, Inc.
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Spectranetics
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Terumo Medical Corporation
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Tryton Medical Inc.
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives

List of Tables

  • 1. List of Abbreviations
  • 2. North America bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 3. North America bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 4. U.S. bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 5. Canada bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 6. Europe bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 7. Europe bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 8. Germany bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 9. UK bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 10. France bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 11. Italy bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 12. Spain bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 13. Sweden bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 14. Norway bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 15. Denmark bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 16. Asia Pacific bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 17. Asia Pacific bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 18. China bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 19. Japan bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 20. India bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 21. Australia bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 22. Thailand bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 23. South Korea bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 24. Latin America bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 25. Latin America bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 26. Brazil bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 27. Mexico bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 28. Argentina bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 29. Middle East and Africa bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 30. Middle East and Africa bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 31. South Africa bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 32. Saudi Arabia bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 33. UAE bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 34. Kuwait bifurcation lesions market, by application, 2018 - 2030 (USD Million)

List of Figure

1. Market research process

2. Data triangulation techniques

3. Primary research pattern

4. Market research approaches

5. Value-chain-based sizing & forecasting

6. QFD modeling for market share assessment

7. Market formulation & validation

8. Bifurcation lesions: Market outlook

9. Bifurcation lesions: Competitive insights

10. Parent market outlook

11. Related/ancillary market outlook

12. Penetration and growth prospect mapping

13. Industry value chain analysis

14. Bifurcation lesions market driver impact

15. Bifurcation lesions market restraint impact

16. Bifurcation lesions market strategic initiatives analysis

17. Bifurcation lesions market: Application movement analysis

18. Bifurcation lesions market: Application outlook and key takeaways

19. Peripheral vascular market estimates and forecasts, 2018 - 2030 (USD Million)

20. Coronary vascular market estimates and forecasts, 2018 - 2030 (USD Million)

21. Global bifurcation lesions market: Regional movement analysis

22. Global bifurcation lesions market: Regional outlook and key takeaways

23. North America market estimates and forecasts, 2018 - 2030 (USD Million)

24. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)

25. Canada market estimates and forecasts, 2018 - 2030 (USD Million)

26. Europe market estimates and forecasts, 2018 - 2030 (USD Million)

27. UK market estimates and forecasts, 2018 - 2030 (USD Million)

28. Germany market estimates and forecasts, 2018 - 2030 (USD Million)

29. France market estimates and forecasts, 2018 - 2030 (USD Million)

30. Italy market estimates and forecasts, 2018 - 2030 (USD Million)

31. Spain market estimates and forecasts, 2018 - 2030 (USD Million)

32. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)

33. Norway market estimates and forecasts, 2018 - 2030 (USD Million)

34. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)

35. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)

36. Japan market estimates and forecasts, 2018 - 2030 (USD Million)

37. China market estimates and forecasts, 2018 - 2030 (USD Million)

38. India market estimates and forecasts, 2018 - 2030 (USD Million)

39. Australia market estimates and forecasts, 2018 - 2030 (USD Million)

40. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)

41. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)

42. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)

43. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)

44. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)

45. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)

46. Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)

47. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)

48. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)

49. UAE market estimates and forecasts, 2018 - 2030 (USD Million)

50. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)